The Data Monitoring Committee (DMC) Initiative addresses the challenge of a limited and diminishing number of experienced candidates available for service on DMCs, in the face of increasing clinical trial monitoring needs. This initiative aims to identify a means of expanding clinical trial sponsors’ access to a broader pool of sufficiently skilled candidates when convening DMCs.
- Enhance skills and number of candidates capable of serving on DMCs, benefiting both individuals desiring to serve on DMCs and sponsors searching for competent DMC members
- More options for Sponsors in selecting DMC members
- Increase DMC Candidate visibility to clinical trial sponsors (thus increase opportunities to impact cutting-edge research)
- Meet anticipated future demand in terms of clinical trial monitoring needs
Please check back for more information.
The Protocol Deviations Initiative is striving for an improved protocol deviation process that should ultimately lead to improved patient safety, reliability of study data, human subject’s protections and data quality.
Risk Based Monitoring
TransCelerate’s Risk Based Monitoring Initiative seeks to develop a model approach for risk-based monitoring of clinical trials, with the goal to both enhance patient safety and ensure the quality of clinical data.
Quality Management System
Through partnerships with Health Authorities and other industry stakeholders, the Quality Management System (QMS) Initiative aims to explore ways to improve quality across the industry.